Aug 30, 2008 4:19 AM ET | Site Changes | Help
Results 1 - 10 of 56 : 1 2 3 4 5 6 Next
These stocks have hit bottom. Are they ready to bounce?
Amylin Answers, Investors Panic
A conference call about side effects doesn't have the desired effect.
Too Much Punishment for Amylin
Several more pancreatitis cases cause investors to panic.
The drugmaker's performance is better than its numbers suggest.
Anemic Amylin's Signs of Recovery
The growth of its main drug is headed in the right direction.
Here's your chance to invest in a category experiencing double-digit growth.
A government review of the company's top drug candidate gets pushed back.
GLP-1 drugs come full circle.
The pharmaceutical's hot streak ends as a vital study fizzles out.
Amylin's Down and Up on Diabetes
So exactly why did it drop and then come back up?
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK